Pay in 4 interest-free payments of $7.22 Learn more
Ships within 48 hours · Estimated delivery Oct 29 - Nov 3
Retatrutide (LY3437943) is Eli Lillys experimental triple-agonist drug that activates: GLP-1 (Glucagon-like peptide-1) reduces appetite and slows digestion GIP (Glucose-dependent insulinotropic peptide) enhances insulin sensitivity Glucagon receptor increases fat metabolism and energy expenditure In phase-2 trials, Retatrutide achieved up to 24% body-weight reduction rivaling or even surpassing bariatric surgery outcomes
This substance has also worked for male-pattern baldness
Side Effects and Safety: Sermorelin vs CJC-1295/Ipamorelin Both protocols have generally mild side effect profiles in healthy patients without contraindications
BPC-157 (10mg vials) Pharmacy Grade BPC-157 Pharmacy Grade BPC-157 Capsules At-Home Blood Test Research Supplies Disclosure: supply links may earn PDP a commission at no cost to you
Use the BPC-157 Dosage Calculator and TB-500 Dosage Calculator for individual dose math
